Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADARx Pharmaceuticals
Biotech
Tang takes over Aurinia after FDA brouhaha—Chutes & Ladders
Tang takes over Aurinia after FDA brouhaha. Abivax, building commercial prowess, snags ex-Takeda exec. Public face of revamped ACIP steps down.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
Mar 27, 2026 11:05am
Moderna CMO steps down in leadership mix-up—Chutes & Ladders
Feb 6, 2026 8:30am
2 ex-Moderna leaders unveil $325M inaugural VC fund
Oct 9, 2025 3:09pm
AbbVie tosses ADARx $335M for siRNA options deal
May 14, 2025 9:00am
ADARx preps 3rd clinical program and mulls IPO
Oct 3, 2023 10:55am
RNA biotech ADARx hauls in healthy $200M series C
Aug 9, 2023 10:17am